Co-Scientist: A multi-agent AI partner to accelerate research

公司动态 Google DeepMind 原文语言:英文

Introducing Co-Scientist, a collaborative AI partner built with Gemini to help researchers accelerate scientific breakthroughs.

全文

Uncovering repurposed medicines to fight liver fibrosis

Co-Scientist helped accelerate Gary Peltz’s search for liver fibrosis treatments. The multi-agent system highlighted overlooked drug-repurposing candidates, including one that successfully blocked 91% of a scarring-linked response in lab tests. The results, published in Advanced Science, point toward new gene-regulating approaches to treat chronic liver disease.

“Co-Scientist feels like a collaborator that’s read everything available about biomedical science, with the reasoning capabilities to find the connections that we’re currently missing.”

Professor Gary Peltz, Stanford University School of Medicine

Read case study

Uniting biological toolkits for a new approach to ALS

Co-Scientist helped unite Ritu Raman and Ryan Flynn’s labs around the degenerative disease, ALS. The system helped Ritu quickly digest complex literature, propose testable ideas, and spot where complementary expertise could strengthen the best leads, sparking collaboration with Ryan on potential RNA-based approaches to ALS.

“Science is a team sport. Co-Scientist can’t do science by itself, and I can’t do it all by myself either. It helps me structure my thoughts, so I know what to ask of other experts and collaborators.”

Associate Professor Ritu Raman, Massachusetts Institute of Technology

Read case study

Fast-tracking genetic leads to reverse cellular aging

Biologists Omar Abudayyeh and Jonathan Gootenberg are using Co‑Scientist to speed up research on reversing cellular aging. The system synthesises decades of literature to propose novel genetic leads that in lab tests have been shown to rejuvenate cells. It also slashes the time needed to analyse huge screening datasets, from months to days.

“Using Co-Scientist feels like having a team of 50 people at your disposal, doing all the work within a day, which isn’t something we can otherwise do with our lab.”

Omar Abudayyeh, Principal Investigator, The Abudayyeh–Gootenberg Lab

Read case study

Accelerating discovery of liver disease mechanisms

For Filippo Menolascina, Co-Scientist helped turn biomedical literature overload into high-quality hypotheses for metabolic liver disease. The system highlighted promising disease mechanisms and drug combinations, and helped explain why an existing drug benefits only some patients – an idea later supported by Menolascina’s lab tests.

“Co‑Scientist feels like a jetpack for scientists, powering up our ability to identify promising mechanisms. I think we’re on the brink of a scientific revolution that will significantly shorten the iteration cycles needed to achieve breakthroughs.”

Filippo Menolascina, Professor of Engineering Biology, University of Edinburgh

Read case study

Finding the molecular switches behind new infectious diseases

Clare Bryant is using Co-Scientist to help identify the proteins that cause severe disease when pathogens like flu and COVID-19 leap from animals to humans. Iterating with the AI system, she rapidly narrowed the hunt to specific amino acids her lab will test — potentially cutting years of experimental work down to months.

“Co-Scientist pulls together the entire published literature and online resources to help me ask better questions. It catches what I'd miss in a data-rich field and helps me prioritise, so my team can focus on answering the right questions in the lab."

Clare Bryant, Professor of Innate Immunity, University of Cambridge

Read case study

Opening new paths in aging research

At Calico Life Sciences, Matt Onsum and Katherine Labbé are using Co-Scientist to tackle one of medicine’s hardest problems: the biology of aging. The AI system has impressed Calico’s experts with its scientific discernment, including by generating an exciting novel hypothesis about the integrated stress response that was later confirmed in the lab.

“What I found both exciting and surprising about using Co-Scientist is how much it thinks like a scientist. It really works naturally with how a scientist already thinks and behaves.”

Dr Matt Onsum, Head of AI/ML, Calico Life Sciences

Read case study

Developing agentic tools with the scientific community

Co-Scientist was developed in collaboration with researchers from over 100 institutions to test its capabilities and ensure it is a high-quality, useful tool for the scientific community.

As part of our responsible AI approach, Co-Scientist underwent extensive internal and external safety evaluations. Given Co-Scientist’s demonstrated proficiency in life and physical sciences, we also conducted independent evaluations for misuse in Chemical, Biological, Radiological and Nuclear (CBRN) domains. From these findings, we developed custom safety classifiers to flag unethical research goals and mitigate the surfacing of unsafe information.

We will continue to iterate and develop the tool alongside feedback and collaboration with the scientific community and are excited to be making Co-Scientist available to individual researchers through Gemini for Science. We also look forward to expanding access to more Google Cloud enterprise partners soon.

We have been deeply inspired by the scientists who have built up our understanding of the world today. And we hope that AI can help researchers to usher in and accelerate a new era of scientific progress.

Note: Co-Scientist is intended to be a partner in research, not a replacement for scientific or clinical expertise, and users are responsible for any decisions they make using the outputs as they continue their scientific journey.

Register your interest

Read our Nature paper

Learn more about Gemini for Science

Acknowledgements

This research project was led by Juraj Gottweis and Vivek Natarajan, as well as Alan Karthikesalingam, Annalisa Pawlosky, and Yunhan Xu, and with key contributions from: Wei-Hung Weng, Adam Marsh, Alexander Daryin, Alessio Orlandi, Andrew Carroll, Anil Palepu, Antonia Mould, Artiom Myaskovsky, Ash Otter, Avinatan Hassidim, Ben Feinstein, Burak Gokturk, Byron Lee, Dan Popovici, Dina Zverinski, Eeshit Dhaval Vaishnav, Elahe Vedadi, Fan Zhang, Felix Weissenberger, Florian Hasler, Frankie Garcia, Gary Peltz, Grzegorz Glowaty, Ivor Rendulic, Ivan Budiselic, Jacob Blum, James Stevenson, Jan Freyberg, Jeremy Ratcliff, Joel Fenster, José R Penadés, Katherine Chou, Kavita Kulkarni, Keran Rong, Khaled Saab, Luka Rimanic, Marina Boia, Mathias Voges, Matthias Bellaiche, Nenad Tomašev, Ottavia Bertolli, Paige Kunkle, Petar Sirkovic, Ryutaro Tanno, Suzy Pickering, Tao Tu, Tiago R D Costa, Tom Sheffer, Victoria Langston, Vikram Dhillon, Yuan Guan, Ziyue Wang, Amin Vahdat, James Manyika, Demis Hassabis, Yossi Matias and Pushmeet Kohli.

We thank our teammates Ali-Cowen Rivers, Anna Trostanetski, Barnaby James, Bill Byrne, Boon Panichprecha, Charlie Taylor, Diego Ballesteros, Hussein Hassan Harrirou, Ieva Grublyte, Ivan Lee, Jakob Oesignhaus, James Walker, Jorge Barrios, Laurynas Tamulevičius, Luka Važić, Meet Shah, Mihai Ciorobea, Natasha Latysheva, Nicolas Stroppa, Nir Kerem, Saz Basu, Sebastian Nowozin, Taylor Applebaum, Team Rakket and, Thomas Wagner and Yaniv Carmel for their technical support.

We also want to thank Carmela Sidrauski, Clare Bryant, Filippo Menolascina, Jonathan Gootenberg, Katherine Labbé, Matthew Onsum, Omar Abudayyeh, Ritu Raman, Ryan Flynn, Velia Siciliano for their collaboration.

Finally, we thank Ali Eslami, Andy Berndt, Ankur Jain, Anna Koivuniemi, Clemens Mayer, Dale Webster, Greg Corrado, Jason Freidenfelds, Jeff Dean, Joelle Barral, John Jumper, John Platt, Josh Woodward, Karen DeSalvo, Koray Kavukcuoglu, Michael Brenner, Michael Howell, Noam Shazeer, Oriol Vinyals, Parthasarathy Ranganathan, Ronit Levavi Morad, Royal Hansen, Scott Huffman, Srini Narayanan, Susan Thomas, Thomas Kurian, Zoubin Ghahramani and Sundar Pichai for their support of this work.

Related posts

Uncovering repurposed medicines to fight liver fibrosis

May 2026Science

Learn more

Uniting biological toolkits for a new approach to ALS

May 2026Science

Learn more

Fast-tracking genetic leads to reverse cellular aging

May 2026Science

Learn more

Accelerating discovery of liver disease mechanisms

May 2026Science

Learn more

Finding the molecular switches behind new infectious diseases

May 2026Science

Learn more

Opening new paths in aging research

May 2026Science

Learn more

正文以来源语言显示。

参考来源

← 返回每日简报